Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2010
10/27/2010EP2243787A2 Peptides binding the phosphatase 2a protein and polynucleotides encoding same
10/27/2010EP2243493A1 Immunopotentiative composition
10/27/2010EP2243492A1 Use of antagonist anti-cd40 monoclonal antibodies for treatment of multiple myeloma
10/27/2010EP2243491A1 Use of antagonist anti-CD40 monoclonal antibodies for treatment of chronic lymphocytic leukemia
10/27/2010EP2242847A2 Transgenic non-human mammal for the constant region of the g-class human immunoglobulin heavy chain and applications thereof
10/27/2010EP2242772A1 Immunoconjugates targeting cd138 and uses thereof
10/27/2010EP2242771A1 Binding molecules to the human ox40 receptor
10/27/2010EP2242770A2 Barb4 target which comprises tata-binding protein-associated factor 15, antibody designated barb4, barb4 related antibodies, and methods of making and using same
10/27/2010EP2242769A2 Cadherin-11 ec1 domain antagonists for treating inflammatory joint disorders
10/27/2010EP2242768A2 Cross-neutralizing human monoclonal antibodies to sars-cov and methods of use thereof
10/27/2010EP2242512A1 Methods for manipulating phagocytosis mediated by cd47
10/27/2010EP1537147B1 Antibody anti hla-dr with an increased adcc and inducing cytokine production
10/27/2010EP1487877B1 Compositions and methods for the diagnosis of tumors
10/27/2010EP1218509B9 Fibroblast growth factor-like polypeptides
10/27/2010EP1112088B1 Method for detecting connective tissue growth factor for diagnosing a renal disorder
10/27/2010CN101874207A A method for characterization of a recombinant polyclonal protein
10/27/2010CN101874042A Method of modifying isoelectric point of antibody via amino acid substitution in cdr
10/27/2010CN101874041A Modified antibody constant region
10/27/2010CN101874040A Immunoglobulin aggregates
10/27/2010CN101871944A Qualitative detection method of tea geometrid nuclear polyhedrosis virus
10/27/2010CN101870981A Expression and purification method of heme oxygenase-1, and epitopes thereof
10/27/2010CN101870731A Polyclone antibody of H-9201, and preparation method and application thereof
10/27/2010CN101870730A Anti-CD-20 monoclonal antibody
10/27/2010CN101249265B Intravenous injection employ persons hepatitis B immune globulin and method of preparing the same
10/27/2010CN101173290B Chemically synthesized HSV1 virus gB glucoprotein extracellular region gene fragment, representation and application of the same
10/26/2010US7820877 Human heavy chain variable regions, human kappa light chain variable regions and encodes only mu isotype; human kappa light chain variable regions and encodes mu and gamma-2 isotypes; double-inactivated mouse Ig locus
10/26/2010US7820807 can bind to and stimulate professional and non-professional human antigen-presenting cells, enhance the stimulatory effect of CD40L on CD40 positive cells and/or induce phenotypical maturation of monocyte derived dendritic cells
10/26/2010US7820798 Tumor necrosis factor-gamma
10/26/2010US7820792 isoform of the alpha 2 delta -4 subunit of a voltage gated calcium channel; useful to identify modulators of the channel subunit; for cancer and inflammation
10/26/2010US7820789 Streptococcal virulence factor for use in developing vaccines for treatment and prevention of pneumonia, meningitis and bacteraemia
10/26/2010US7820787 Immunotherapy; antitumor agents
10/26/2010US7820633 cytotoxic T-cell mediated killing of disease cells that express a weakly immunogenic or non-immunogenic cell-associated polypeptide antigen in an animal by administering a cytotoxic T-cell epitope and a T-helper lymphocyte
10/26/2010US7820620 Cripto antagonism of activin and TGF-b signaling
10/26/2010US7820447 drug screening; for carcinomas, especially lymphoma carcinomas
10/26/2010US7820410 Proteins with high immunoreactivity and method for their production
10/26/2010US7820400 Tumor-associated marker
10/26/2010US7820395 diagnostic method and vaccine using a composition comprising truncated r47 protein and truncated r56 protein; reducing HIV viral loads
10/26/2010US7820393 Immunoglobulin which recognizes multiple antigenic peptides (MAP) for use in the diagnosis and differentiation between glandular and bone disorders
10/26/2010US7820379 Process for high throughput screening of CpG-based immuno-agonist/antagonist
10/26/2010US7820178 VEGF isoforms and their use as anti-angiogenic, anti-vasodilatory, anti-permeability and anti-proliferative agents
10/26/2010US7820170 monoclonal antibody exhibit antagonist activity of the anti-CD40 antibody; antiproliferative agents; controlling cell differentiation; anticarcinogenic agents; Hodgkin's disease, leukemias
10/26/2010US7820169 inhibiting the activity of tumor necrosis factor TNF in a patient having rheumatoid arthritis or psoriatic arthritis, by administering a composition comprising an effective amount of human anti-TNF antibody comprising a heavy chain variable region comprising SEQ ID NO:7 and a light chain variable
10/26/2010US7820167 IL1-β: a new target for myeloma therapy
10/26/2010US7820166 Potent T cell modulating molecules
10/26/2010US7820165 anti-epidermal growth factor receptor (EGFR) fusion protein; for development of diagnostics and therapeutics
10/26/2010US7820164 antibody binds target tissue and conjugate carrying epitope (haptens); monoclonal antibody or fragment thereof binds to a colon-specific antigen-p mucin (CSAp) antigen - the Mu-9 epitope; DNA sequence; colon cancer
10/26/2010US7820163 Anti-hepcidin antibodies and uses thereof
10/26/2010US7820162 Methods for chemically synthesizing immunoglobulin chimeric proteins
10/26/2010US7820161 Treatment of autoimmune diseases
10/26/2010CA2579391C Anti-a33 antibody
10/26/2010CA2443840C Cripto blocking antibodies and uses thereof
10/26/2010CA2351887C Psca: prostate stem cell antigen and uses thereof
10/26/2010CA2330639C Method for producing a specific antiserum against the universal tumorous antigen and method for diagnosing malignant tumours using said antiserum
10/26/2010CA2326501C Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis
10/26/2010CA2284733C Motilin homologs
10/26/2010CA2197717C Mycobacteria functional screening and/or expression vectors
10/26/2010CA2178941C Transgenic production of antibodies in milk
10/21/2010WO2010121140A1 ANTI-TNF-α ANTIBODIES AND THEIR USES
10/21/2010WO2010120726A1 Treatment of inflammatory diseases by inhibiting cold- inducible rna-binding protein (cirp)
10/21/2010WO2010120561A1 Anti-fcrh5 antibodies and immunoconjugates and methods of use
10/21/2010WO2010120554A1 Detecting and treating breast cancer resistance to egfr inhibitors
10/21/2010WO2010120501A2 Assys for bacterial detection and identification
10/21/2010WO2010120069A2 Antigenic protein of black-lip pearl oyster egg extract, and method for assessing productive effort of black-lip pearl oyster using antibody specific to the protein
10/21/2010WO2010119991A2 Novel method of treating cancer
10/21/2010WO2010119704A1 Antibodies that specifically bind to a beta oligomers and use thereof
10/21/2010WO2010119691A1 Diagnosis and treatment of cancer using anti-tmprss11e antibody
10/21/2010WO2010119249A1 Therapeutic antennapedia-antibody molecules and methods of use thereof
10/21/2010WO2010119119A1 USE OF TRIFUNCTIONAL BISPECIFIC ANTIBODIES FOR THE TREATMENT OF TUMORS ASSOCIATED WITH CD133+/EpCAM+CANCER STEM CELLS
10/21/2010WO2010119021A1 Tenascin-w and brain cancers
10/21/2010WO2010118985A1 Affinity material
10/21/2010WO2010118890A1 B-lymphocyte targeting agents for use in a method for the treatment of a disease
10/21/2010WO2010118522A1 Antibodies against prostate specific membrane antigen
10/21/2010WO2010099153A3 Metabolic engineering of a galactose assimilation pathway in the glycoengineered yeast pichia pastoris
10/21/2010WO2010078950A3 Antigens associated with endometriosis, psoriatic arthritis and psoriasis
10/21/2010WO2010072740A3 TARGETED BINDING AGENTS DIRECTED TO α5β1 AND USES THEREOF
10/21/2010WO2010055366A3 Anti-human il-21 monoclonal antibodies
10/21/2010WO2010047509A3 Anti-dr5 antibody with improved affinity and stability, and composition for cancer prevention or treatment including same
10/21/2010WO2009134711A8 Humanized anti-factor d antibodies and uses thereof
10/21/2010WO2009109368A8 Identification of antigen- or ligand-specific binding proteins
10/21/2010US20100269184 Apo-2DcR
10/21/2010US20100267938 Use of antibody-surrogate antigen systems for detection of analytes
10/21/2010US20100267937 Cyanine Dye Labelling Reagents
10/21/2010US20100267936 PROCESS FOR CORRECTION OF A DISULFIDE MISFOLD IN Fc MOLECULES
10/21/2010US20100267935 Antibody having inhibitory effect on amyloid fibril formation
10/21/2010US20100267934 Stable igg4 antibodies
10/21/2010US20100267930 SLO2 and SLO4, Novel Potassium Channel Proteins from Human Brain
10/21/2010US20100267927 Structure of the Insulin Receptor Ectodomain
10/21/2010US20100267816 Human anti-amyloid beta peptide antibody and fragment of said antibody
10/21/2010US20100267649 Vascular adhesion molecules and modulation of their function
10/21/2010US20100267646 Trophic Factor for the Treatment of Retinal Degenerative Diseases
10/21/2010US20100267580 Method for detection of a disease-specific combinatorial molecular pattern motif in a tissue sample of a patient's skin
10/21/2010US20100267139 Osteopontin nanoparticle system for drug delivery
10/21/2010US20100267138 Compositions and methods comprising a ligand of chemerinr
10/21/2010US20100267131 Feline Pancreatic Lipase
10/21/2010US20100267060 High sensitivity secretagogin assays and their uses for diagnosis and/or prognosis
10/21/2010US20100267058 Circulating ret receptor
10/21/2010US20100267056 Differential labelling method
10/21/2010US20100267045 Cudr as biomarker for cancer progression and therapeutic response
10/21/2010US20100267027 Her-2 binding antagonists
10/21/2010US20100267022 Monocyte-derived nucleic acids and related compositions and methods
1 ... 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 ... 1494